PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33524820-0	2021	Multi-spectroscopic and molecular docking studies for binding interaction between fluvoxamine and human serum albumin.	Fluvoxamine	82-93	albumin	Homo sapiens	104-117	
33524820-1	2021	In the present study, different spectroscopic techniques have been used to study the binding interaction between the antidepressant drug fluvoxamine and human serum albumin under simulated physiological conditions (pH 7.4).	Fluvoxamine	137-148	albumin	Homo sapiens	159-172	
33524820-3	2021	The obtained results revealed that the formation of a complex between human serum albumin and fluvoxamine was responsible for quenching the native fluorescence of human serum albumin.	Fluvoxamine	94-105	albumin	Homo sapiens	76-89	
33524820-3	2021	The obtained results revealed that the formation of a complex between human serum albumin and fluvoxamine was responsible for quenching the native fluorescence of human serum albumin.	Fluvoxamine	94-105	albumin	Homo sapiens	169-182	
33524820-4	2021	The results indicated that the quenching mechanism between human serum albumin and fluvoxamine was static.	Fluvoxamine	83-94	albumin	Homo sapiens	65-78	
33524820-7	2021	From the molecular docking results, it could be deduced that fluvoxamine was inserted into sub-domain II A (site I) of human serum albumin and led to a slight change in human serum albumin conformation.	Fluvoxamine	61-72	albumin	Homo sapiens	125-138	
33524820-7	2021	From the molecular docking results, it could be deduced that fluvoxamine was inserted into sub-domain II A (site I) of human serum albumin and led to a slight change in human serum albumin conformation.	Fluvoxamine	61-72	albumin	Homo sapiens	175-188